Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 14, Number 2—February 2008
Research

Genetic Characterization of Feline Leukemia Virus from Florida Panthers

Meredith A. Brown*, Mark W. Cunningham†, Alfred L. Roca*‡§, Jennifer L. Troyer*§, Warren E. Johnson*, and Stephen J. O’Brien*Comments to Author 
Author affiliations: *National Cancer Institute, Frederick, Maryland, USA; †Florida Fish and Wildlife Conservation Commission, Gainesville, Florida, USA; ‡University of Illinois at Urbana-Champaign, Urbana, Illinois, USA; §SAIC-Frederick, Frederick, Maryland, USA;

Main Article

Figure 2

A) Diagram of the feline leukemia virus (FeLV) genome showing the PCR products obtained from FeLV-Pco env and long terminal repeat (LTR) genes. Envelope gene surface (SU) and transmembrane (TM) subunits, variable regions A and B (VRA and VRB) and the proline-rich region (PRR), 3’ LTR enhancer element(s) (hatched rectangle), signature 21-bp repeat(s) (gray shading), and putative c-Myb binding sites (black triangles) (12) are depicted for FeLV-945, FeLV-Pco, and FeLV-3281A . Unique signature amino acid residues found only in FeLV-945 and FeLV-Pco are marked by asterisks (see Figure 5). B) Primer pair PfeF6/PfeR6 was designed to detect all FeLV subgroups.

Figure 2. A) Diagram of the feline leukemia virus (FeLV) genome showing the PCR products obtained from FeLV-Pco env and long terminal repeat (LTR) genes. Envelope gene surface (SU) and transmembrane (TM) subunits, variable regions A and B (VRA and VRB) and the proline-rich region (PRR), 3’ LTR enhancer element(s) (hatched rectangle), signature 21-bp repeat(s) (gray shading), and putative c-Myb binding sites (black triangles) (12) are depicted for FeLV-945, FeLV-Pco, and FeLV-3281A . Unique signature amino acid residues found only in FeLV-945 and FeLV-Pco are marked by asterisks (see Figure 5). B) Primer pair PfeF6/PfeR6 was designed to detect all FeLV subgroups.

Main Article

References
  1. Culver  M, Johnson  WE, Pecon-Slattery  J, O’Brien  SJ. Genomic ancestry of the American puma (Puma concolor). J Hered. 2000;91:186–97. DOIPubMedGoogle Scholar
  2. Roelke  ME, Martenson  JS, O’Brien  SJ. The consequences of demographic reduction and genetic depletion in the endangered Florida panther. Curr Biol. 1993;3:340–50. DOIPubMedGoogle Scholar
  3. Roelke  ME, Forrester  DJ, Jacobson  ER, Kollias  GV, Scott  FW, Barr  MC, Seroprevalence of infectious disease agents in free-ranging Florida panthers (Felis concolor coryi). J Wildl Dis. 1993;29:36–49.PubMedGoogle Scholar
  4. Maehr  DS, Lacy  R. Avoiding the lurking pitfalls in Florida panther recovery. Wildl Soc Bull. 2002;30:971–8.
  5. Cunningham  MW, Brown  MA, Shindle  DB, Terrell  SP, Hayes  KA, Ferree  BC, Epizootiology and management of feline leukemia virus in the Florida puma. J Wildl Dis. In press.
  6. Hardy  WD Jr, Old  LJ, Hess  PW, Essex  M, Cotter  S. Horizontal transmission of feline leukaemia virus. Nature. 1973;244:266–9. DOIPubMedGoogle Scholar
  7. Jarrett  WF, Crawford  EM, Martin  WB, Davie  F. A virus-like particle associated with leukemia (lymphosarcoma). Nature. 1964;202:567–9. DOIPubMedGoogle Scholar
  8. Mullins  JI, Hoover  EA. Molecular aspects of feline leukemia virus pathogenesis. In: Gallo RC, Wong-Staal F, editors. Retrovirus biology and human disease. New York: Dekker; 1990. p. 87–116.
  9. Denner  J. How does HIV induce AIDS? The virus protein hypothesis. J Hum Virol. 2000;3:81–2.PubMedGoogle Scholar
  10. Abujamra  AL, Faller  DV, Ghosh  SK. Mutations that abrogate transactivational activity of the feline leukemia virus long terminal repeat do not affect virus replication. Virology. 2003;309:294–305. DOIPubMedGoogle Scholar
  11. Chandhasin  C, Coan  PN, Pandrea  I, Grant  CK, Lobelle-Rich  PA, Puetter  A, Unique long terminal repeat and surface glycoprotein gene sequences of feline leukemia virus as determinants of disease outcome. J Virol. 2005;79:5278–87. DOIPubMedGoogle Scholar
  12. Finstad  SL, Prabhu  S, Rulli  KR, Levy  LS. Regulation of FeLV-945 by c-Myb binding and CBP recruitment to the LTR. Virol J. 2004;1:3. DOIPubMedGoogle Scholar
  13. Overbaugh  J, Bangham  CR. Selection forces and constraints on retroviral sequence variation. Science. 2001;292:1106–9. DOIPubMedGoogle Scholar
  14. Phipps  AJ, Hayes  KA, Al-dubaib  M, Roy-Burman  P, Mathes  LE. Inhibition of feline leukemia virus subgroup A infection by coinoculation with subgroup B. Virology. 2000;277:40–7. DOIPubMedGoogle Scholar
  15. Stewart  MA, Warnock  M, Wheeler  A, Wilkie  N, Mullins  JI, Onions  DE, Nucleotide sequences of a feline leukemia virus subgroup A envelope gene and long terminal repeat and evidence for the recombinational origin of subgroup B viruses. J Virol. 1986;58:825–34.PubMedGoogle Scholar
  16. Okabe  H, Twiddy  E, Gilden  RV, Hatanaka  M, Hoover  EA, Olsen  RG. FeLV-related sequences in DNA from a FeLV-free cat colony. Virology. 1976;69:798–801. DOIPubMedGoogle Scholar
  17. Neil  JC, Fulton  R, Rigby  M, Stewart  M. Feline leukaemia virus: generation of pathogenic and oncogenic variants. Curr Top Microbiol Immunol. 1991;171:67–93.PubMedGoogle Scholar
  18. Donahue  PR, Quackenbush  SL, Gallo  MV, deNoronha  CM, Overbaugh  J, Hoover  EA, Viral genetic determinants of T-cell killing and immunodeficiency disease induction by the feline leukemia virus FeLV-FAIDS. J Virol. 1991;65:4461–9.PubMedGoogle Scholar
  19. Thompson  JD, Gibson  TJ, Plewniak  F, Jeanmougin  F, Higgins  DG. The CLUSTAL X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 1997;25:4876–82. DOIPubMedGoogle Scholar
  20. Maddison  DR, Maddison  WP. MacClade 3.05. Sunderland (MA): Sinauer Associates; 1995.
  21. Posada  D, Crandall  KA. MODELTEST: testing the model of DNA substitution. Bioinformatics. 1998;14:817–8. DOIPubMedGoogle Scholar
  22. Kumar  S, Tamura  K, Nei  M. MEGA3: Integrated software for molecular evolutionary genetics analysis and sequence alignment. Brief Bioinform. 2004;5:150–63. DOIPubMedGoogle Scholar
  23. Benveniste  RE, Todaro  GJ. Segregation of RD-114 and FeLV-related sequences in crosses between domestic cat and leopard cat. Nature. 1975;257:506–8. DOIPubMedGoogle Scholar
  24. Reeves  RH, O’Brien  SJ. Molecular genetic characterization of the RD-114 gene family of endogenous feline retroviral sequences. J Virol. 1984;52:164–71.PubMedGoogle Scholar
  25. Chandhasin  C, Coan  PN, Levy  LS. Subtle mutational changes in the SU protein of a natural feline leukemia virus subgroup A isolate alter disease spectrum. J Virol. 2005;79:1351–60. DOIPubMedGoogle Scholar
  26. Chandhasin  C, Lobelle-Rich  P, Levy  LS. Feline leukaemia virus LTR variation and disease association in a geographical and temporal cluster. J Gen Virol. 2004;85:2937–42. DOIPubMedGoogle Scholar
  27. Roelke  ME, Pecon-Slattery  J, Taylor  S, Citino  S, Brown  E, Packer  C, T-lymphocyte profiles in FIV-infected wild lions and pumas reveal CD4 depletion. J Wildl Dis. 2006;42:234–48.PubMedGoogle Scholar
  28. Cohen  ND, Carter  CN, Thomas  MA, Lester  TL, Eugster  AK. Epizootiologic association between feline immunodeficiency virus infection and feline leukemia virus seroPositivity. J Am Vet Med Assoc. 1990;197:220–5.PubMedGoogle Scholar
  29. Ishida  T, Washizu  T, Toriyabe  K, Motoyoshi  S, Tomoda  I, Pedersen  NC. Feline immunodeficiency virus infection in cats of Japan. J Am Vet Med Assoc. 1989;194:221–5.PubMedGoogle Scholar
  30. Lee  IT, Levy  JK, Gorman  SP, Crawford  PC, Slater  MR. Prevalence of feline leukemia virus infection and serum antibodies against feline immunodeficiency virus in unowned free-roaming cats. J Am Vet Med Assoc. 2002;220:620–2. DOIPubMedGoogle Scholar
  31. O’Connor  TP Jr, Tonelli  QJ, Scarlett  JM. Report of the National FeLV/FIV Awareness Project. J Am Vet Med Assoc. 1991;199:1348–53.PubMedGoogle Scholar
  32. Yamamoto  JK, Hansen  H, Ho  EW, Morishita  TY, Okuda  T, Sawa  TR, Epidemiologic and clinical aspects of feline immunodeficiency virus infection in cats from the continental United States and Canada and possible mode of transmission. J Am Vet Med Assoc. 1989;194:213–20.PubMedGoogle Scholar
  33. Troyer  JL, Pecon-Slattery  J, Roelke  ME, Johnson  W, VandeWoude  S, Vazquez-Salat  N, Seroprevalence and genomic divergence of circulating strains of feline immunodeficiency virus among Felidae and Hyaenidae species. J Virol. 2005;79:8282–94. DOIPubMedGoogle Scholar
  34. Paul-Murphy  J, Work  T, Hunter  D, McFie  E, Fjelline  D. Serologic survey and serum biochemical reference ranges of the free-ranging mountain lion (Felis concolor) in California. J Wildl Dis. 1994;30:205–15.PubMedGoogle Scholar
  35. Osofsky  SA, Hirsch  KJ, Zuckerman  EE, Hardy  WD. Feline lentivirus and feline oncovirus status of free-ranging lions (Panthera leo), leopards (Panthera pardus), and cheetahs (Acinonyx jubatus) in Botswana: a regional perspective. J Zoo Wildl Med. 1996;27:453–67.
  36. Jessup  D. Feline leukemia virus infection and renal spirochetosis in a free-ranging cougar (Felis concolor). J Zoo Wildl Med. 1993;24:73–9.
  37. Roelke  ME, Martenson  JS, O’Brien  SJ. The consequences of demographic reduction and genetic depletion in the endangered Florida panther. Curr Biol. 1993;3:340–50. DOIPubMedGoogle Scholar
  38. Pontius  JU, Mullikin  JC, Smith  DR, Agencourt Sequencing Team, Lindblad-Toh K, Gnerre S, et al. Initial sequence and comparative analysis of the cat genome. Genome Res. 2007;17:1675–89. DOIPubMedGoogle Scholar

Main Article

Page created: July 12, 2010
Page updated: July 12, 2010
Page reviewed: July 12, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external